Melissa M Ong1, Alexander Schmidt1, Simon Konstandin2, Justus Benrath3, Mathias Meyer1, Lothar R Schad4, Stefan O Schoenberg1, and Stefan Haneder1,5
1Institute of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany, 2University of Bremen, MR-Imaging and Spectroscopy, Faculty 01 (Physics/Electrical Engineering), Bremen, Germany, 3Clinic for Anaesthesiology and Operative Intensive Care, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany, 4Computer Assisted Clinical Medicine, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany, 5Institute of Diagnostic and Interventional Radiology, University Hospital Cologne, Cologne, Germany
Synopsis
To evaluate sodium concentrations in subgroups of
patients with clinically manifest migraine, 12 patients underwent a cerebral 23Na-magnetic
resonance imaging examination using a dual-tuned (23Na/1H),
dedicated head-coil. 23Na-sequences were reconstructed according to a
T1 MP-RAGE, allowing direct cross-referencing of predetermined regions-of-interest
(ROI). Significant differences in sodium concentrations could be observed for
the white matter and anterior cerebrospinal fluid in patients with and without
accompanying aura (p<0.05). These data suggest, that cerebral sodium
concentrations may have the potential to differentiate between different
subgroups of migraine.
Purpose
Migraine
is one of the most common headache disorders with a prevalence of about 18% in
women and 6% in men. 20% of all patients with migraine report aura-symptoms. A
recent study by Harrington et. al [1] of a rat migraine model supports a role
of sodium in migraine, with rising sodium levels that increase neuronal
excitability. The feasibility of cerebral 23Na-MRI for in-vivo
imaging has been demonstrated in several studies, including imaging in stroke, brain
tumors and multiple sclerosis [2-4]. So far, no study has been published that
investigated the impact of sodium concentrations in patients with migraine.
Thus, the purpose of this study was the evaluation of sodium concentrations in
subgroups of patients with clinically manifest migraine.Methods
In
this prospective, IRB-approved study we recruited 12 otherwise healthy patients
(all female; mean age 34±11 years) who had been diagnosed for migraine symptoms
according the criteria of the International Headache Society (IHS). The
patients filled out a questionnaire regarding onset of disease, length,
intensity (scale 0 -10) and frequency of migraine attacks and accompanying
aura. The patients underwent a cerebral 23Na-magnetic resonance imaging
examination at 3.0T (MAGNETOM Tim Trio, Siemens Healthcare Sector, Erlangen,
Germany). For each scan a non-contrast enhanced T1w MP-RAGE sequence for
anatomical referencing and a 3D-density-adapted, radial gradient echo (GRE-)
sequence [5] for 23Na-imaging were acquired using a dual-tuned (23Na/1H),
dedicated head-coil (Rapid Biomedical GmbH, Rimpar, Germany). The following
scan parameters were used: TR 120msec; TE 0.2 msec; 17000 projections; flip
angle 87°; spatial resolution 3.6x3.6x3.6mm3. 23Na-sequences
were reconstructed according to the MP-RAGE, allowing direct cross-referencing
of regions-of-interest (ROI). Circular ROIs were placed in predetermined anatomic
regions: cerebrospinal fluid (CSF), grey and white matter (GM/WM), brain stem
and cerebellum. External sodium reference phantoms with 5% and 2% agar gel and sodium concentrations of 154
millimoles and 50 millimoles were used to calculate the tissue sodium concentrations
(TSC). Kendall Tau and Wilcoxon rank sum test were used for statistical
analysis (JMP 10.0 SAS Institute Inc., Cary, North Carolina, USA).Results
Significant differences in sodium concentration could be
observed for the WM and anterior CSF in patients with and without accompanying
aura (p<0.05). Moderate to good correlation
was observed between time interval to last attack and anterior CSF and disease
onset with TSC in GM, posterior CSF, brain stem and cerebellum (r ≥ 0.4).
Furthermore, pain intensity and TSC in GM, CSF and brainstem showed a moderate
correlation (r = 0.4-0.5). Overall sodium concentration of all patients (in millimoles per liter) averaged 35±4, 41±3, 81±8, 87±6 and 33±4 and 33±3 for WM, GM, anterior and posterior CSF, brainstem and cerebellum, respectively.Discussion
The diagnosis of migraine in a clinical setting is
challenging, because intra-individual migraine characteristics and type of
attacks vary among patients. The diagnostic criteria of the IHS and further
questionnaires are helpful in most cases. Nonetheless, many migraine patients are
undiagnosed and therefore undertreated. In contrast, there are patients treated
incorrectly with medication against migraine who suffer from other types of
headache, e.g. tension-type headache. Therefore, it would be helpful to have
a diagnostic tool supporting or even diagnosing migraine and differentiating
migraine from other types of headaches. Knowing the distribution of sodium
concentrations in brain structures for different subgroups of migraine may have
the potential of providing a more objective clinical evaluation tool in the
future. Conclusion
Cerebral sodium MRI may have the potential to
differentiate between different subgroups of migraine. This could lead to an enhanced and individualized therapy.Acknowledgements
No acknowledgement found.References
1. Harrington, Michael G et al. “Sodium MRI in a
Rat Migraine Model and a NEURON Simulation Study Support a Role for Sodium in
Migraine.” Cephalalgia?: an
international journal of headache 31.12
(2011): 1254–1265. PMC.
Web. 7 Nov. 2016.
2. Neumaier-Probst, E et al. “A double-tuned 1H/23Na resonator
allows 1H-guided 23Na-MRI in ischemic stroke
patients in one session.” Int J Stroke
(2015), 10: 56–61. doi:10.1111/ijs.12547
3. Haneder, S et. al. “23Na-MRI
of recurrent glioblastoma multiforme after intraoperative radiotherapy:
technical note.” Neuroradiology (2015) 57: 321.
doi:10.1007/s00234-014-1468-2
4. Eisele, P et. al “Heterogeneity of acute multiple sclerosis
lesions on sodium (23Na) MRI.” Mult Scler July 2016 22: 1040-1047, first
published on October 9, 2015 doi:10.1177/1352458515609430
5. Nagel, A. et. al. "Sodium MRI using a
density-adapted 3D radial acquisition technique." Magn. Reson. Med. (2009), 62:
1565–1573. doi:10.1002/mrm.22157